Biotech

All Articles

Boundless Bio makes 'modest' cutbacks 5 months after $100M IPO

.Only five months after securing a $100 thousand IPO, Limitless Bio is actually presently laying off...

Halda's $126M will accelerate 'keep as well as kill' cyst medicines

.The first stages of oncology R&ampD may not be short of fascinating brand new modalities, and also ...

Lykos 'remorses' not revealing research study offenses along with author

.Psychopharmacology has actually pulled three write-ups regarding midstage professional trial data d...

Analysts go into Avidity's DMD succeed, exposing subtleties in records

.Avidity Biosciences amazed capitalists with phase 1/2 records in Duchenne muscle dystrophy (DMD) Fr...

Actinogen's cortisol blocker stops working period 2 depression study

.Actinogen Medical's cortisol blocker has actually missed out on the primary endpoint of a stage 2 s...

Bivictrix determines going exclusive only way to take ADC into clinic

.Antibody-drug conjugates (ADCs) have been at the center of lots of a billion-dollar biobuck licensi...

TPG tops up funds to $580M for expenditures throughout life scientific researches

.Possession supervisor TPG, which has assisted biotechs such as Sionna Therapies and also Santa Ana ...

Merck stops phase 3 TIGIT trial in lung cancer for futility

.Merck &amp Co.'s TIGIT plan has actually endured an additional drawback. Months after shuttering a ...

After a tough year, Exscientia folds up in to Recursion

.After a year specified through pipeline cuts, the variation of its CEO as well as cutbacks, Exscien...

Cullinan, after $25M bargain, hands back bispecific to Port

.Cullinan Therapy was actually made an impression on enough along with Harbour BioMed's bispecific i...